Therapeutic potential of bromelain in 6-hydroxydopamine rat model of parkinson's disease

Conference ObjectAçık Erişim

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/17003Resmi atıflarda kullanılan kalıcı adres
Tam Kayıt
AlanDeğerDil
dc.contributor.authorCicek, B.
dc.contributor.authorGul, M.
dc.contributor.authorTaghizadehghalehjoughi, A.
dc.contributor.authorOkkay, U.
dc.contributor.authorYildirim, S.
dc.contributor.authorOkkay, I. F.
dc.contributor.authorErtugrul, M. S.
dc.contributor.authorAydin, I. C.
dc.contributor.authorBayram, C.
dc.contributor.authorArslan, Y. K.
dc.contributor.authorHacimuftuoglu, A.
dc.date.accessioned2026-10-18T20:41:12.346179844Z
dc.date.available2026-10-18T20:41:12.346179844Z
dc.date.issued2020
dc.description.sponsorshipThis study is part of Betul Cicek's doctorate thesis. This study is supported by Ataturk University BAP Project number: TDK-2019-6996.
dc.identifier.doi10.1016/j.euroneuro.2020.09.569
dc.identifier.eissn1873-7862
dc.identifier.endpageS439
dc.identifier.issn0924-977X
dc.identifier.startpageS438
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/17003
dc.identifier.volume40
dc.identifier.wosWOS:000593520800556
dc.language.isoen
dc.publisherELSEVIER
dc.relation.ispartofEUROPEAN NEUROPSYCHOPHARMACOLOGY
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectClinical Neurology
dc.subjectNeurosciences
dc.subjectPharmacology & Pharmacy
dc.subjectPsychiatry
dc.subjectNeurosciences & Neurology
dc.titleTherapeutic potential of bromelain in 6-hydroxydopamine rat model of parkinson's disease
dc.typeConference Object
dspace.entity.typePublication
rdl.citation.wos1
rdl.oa.statusgreen
rdl.source.indexWOS
rdl.wos.indexScience Citation Index Expanded (SCI-EXPANDED)
rdl.wos.indexConference Proceedings Citation Index - Science (CPCI-S)